Stockreport

Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm [Seeking Alpha]

Cardiff Oncology, Inc.  (CRDF) 
PDF Recent phase 2 CRDF-004 data showed diminished response rates for onvansertib versus earlier readouts, though both doses outperformed control. Cash runway extends int [Read more]